Jane L. Cross

526 total citations
19 papers, 439 citations indexed

About

Jane L. Cross is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Neurology. According to data from OpenAlex, Jane L. Cross has authored 19 papers receiving a total of 439 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 7 papers in Cellular and Molecular Neuroscience and 4 papers in Neurology. Recurrent topics in Jane L. Cross's work include RNA Interference and Gene Delivery (8 papers), Neuroscience and Neuropharmacology Research (5 papers) and Neonatal and fetal brain pathology (4 papers). Jane L. Cross is often cited by papers focused on RNA Interference and Gene Delivery (8 papers), Neuroscience and Neuropharmacology Research (5 papers) and Neonatal and fetal brain pathology (4 papers). Jane L. Cross collaborates with scholars based in Australia, Belgium and United States. Jane L. Cross's co-authors include Bruno P. Meloni, Neville W. Knuckey, Ryan S. Anderton, Diego Milani, Adam B. Edwards, N. Knuckey, Anthony J. Bakker, David Blacker, R.M. Hopkins and Katrin Hoffmann and has published in prestigious journals such as PLoS ONE, Journal of Neurochemistry and Journal of Cerebral Blood Flow & Metabolism.

In The Last Decade

Jane L. Cross

19 papers receiving 436 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jane L. Cross Australia 11 280 92 71 65 62 19 439
Xiaofei Ji China 9 214 0.8× 45 0.5× 44 0.6× 38 0.6× 5 0.1× 24 471
Mohammed Al‐Hawwas Australia 14 194 0.7× 65 0.7× 12 0.2× 16 0.2× 24 0.4× 24 377
Jie Peng China 8 216 0.8× 78 0.8× 7 0.1× 19 0.3× 29 0.5× 13 495
Zhanwen He China 10 206 0.7× 45 0.5× 5 0.1× 20 0.3× 19 0.3× 33 360
Kiersten L. Berggren United States 10 129 0.5× 51 0.6× 6 0.1× 25 0.4× 9 0.1× 15 300
Moon‐Sook Woo United States 7 149 0.5× 42 0.5× 4 0.1× 40 0.6× 45 0.7× 11 403
Takuro Kobori Japan 13 136 0.5× 55 0.6× 4 0.1× 72 1.1× 36 0.6× 34 438
Breset A. Walker United States 6 303 1.1× 139 1.5× 3 0.0× 116 1.8× 46 0.7× 6 494
Shengtao Yao China 11 159 0.6× 45 0.5× 4 0.1× 75 1.2× 9 0.1× 19 414

Countries citing papers authored by Jane L. Cross

Since Specialization
Citations

This map shows the geographic impact of Jane L. Cross's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jane L. Cross with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jane L. Cross more than expected).

Fields of papers citing papers by Jane L. Cross

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jane L. Cross. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jane L. Cross. The network helps show where Jane L. Cross may publish in the future.

Co-authorship network of co-authors of Jane L. Cross

This figure shows the co-authorship network connecting the top 25 collaborators of Jane L. Cross. A scholar is included among the top collaborators of Jane L. Cross based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jane L. Cross. Jane L. Cross is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Anderton, Ryan S., et al.. (2020). Effect of Polyarginine Peptide R18D Following a Traumatic Brain Injury in Sprague-Dawley Rats. Current Therapeutic Research. 92. 100584–100584. 4 indexed citations
2.
Anderton, Ryan S., et al.. (2019). Poly-arginine Peptide R18D Reduces Neuroinflammation and Functional Deficits Following Traumatic Brain Injury in the Long-Evans Rat. International Journal of Peptide Research and Therapeutics. 25(4). 1563–1572. 10 indexed citations
3.
Edwards, Adam B., Jane L. Cross, Ryan S. Anderton, Neville W. Knuckey, & Bruno P. Meloni. (2018). Poly-arginine R18 and R18D (D-enantiomer) peptides reduce infarct volume and improves behavioural outcomes following perinatal hypoxic-ischaemic encephalopathy in the P7 rat. Molecular Brain. 11(1). 8–8. 29 indexed citations
4.
5.
Edwards, Adam B., Kirk W. Feindel, Jane L. Cross, et al.. (2017). Neuroprotective efficacy of poly-arginine-18 (R18) peptides using an in vivo model of perinatal hypoxic ischaemic encephalopathy (HIE). Journal of Cerebral Blood Flow & Metabolism. 37. 18–19. 3 indexed citations
6.
7.
Milani, Diego, Jane L. Cross, Ryan S. Anderton, et al.. (2017). Delayed 2-h post-stroke administration of R18 and NA-1 (TAT-NR2B9c) peptides after permanent and/or transient middle cerebral artery occlusion in the rat. Brain Research Bulletin. 135. 62–68. 8 indexed citations
8.
Edwards, Adam B., Kirk W. Feindel, Jane L. Cross, et al.. (2017). Modification to the Rice-Vannucci perinatal hypoxic-ischaemic encephalopathy model in the P7 rat improves the reliability of cerebral infarct development after 48 hours. Journal of Neuroscience Methods. 288. 62–71. 29 indexed citations
9.
Milani, Diego, Jane L. Cross, Ryan S. Anderton, et al.. (2016). Neuroprotective efficacy of poly-arginine R18 and NA-1 (TAT-NR2B9c) peptides following transient middle cerebral artery occlusion in the rat. Neuroscience Research. 114. 9–15. 45 indexed citations
10.
Milani, Diego, et al.. (2016). Poly-arginine peptides reduce infarct volume in a permanent middle cerebral artery rat stroke model. BMC Neuroscience. 17(1). 19–19. 31 indexed citations
11.
Milani, Diego, N. Knuckey, Ryan S. Anderton, Jane L. Cross, & Bruno P. Meloni. (2016). The R18 Polyarginine Peptide Is More Effective Than the TAT-NR2B9c (NA-1) Peptide When Administered 60 Minutes after Permanent Middle Cerebral Artery Occlusion in the Rat. Stroke Research and Treatment. 2016. 1–9. 34 indexed citations
12.
Meloni, Bruno P., Jane L. Cross, Adam B. Edwards, et al.. (2015). Poly-Arginine and Arginine-Rich Peptides are Neuroprotective in Stroke Models. Journal of Cerebral Blood Flow & Metabolism. 35(6). 993–1004. 71 indexed citations
13.
Meloni, Bruno P., et al.. (2013). FAST-Mag protocol with or without mild hypothermia (35C) does not improve outcome after permanent MCAO in rats. Magnesium Research. 26(2). 67–73. 6 indexed citations
14.
Cross, Jane L., Sherif Boulos, Sharon Lee, et al.. (2012). High level over-expression of different NCX isoforms in HEK293 cell lines and primary neuronal cultures is protective following oxygen glucose deprivation. Neuroscience Research. 73(3). 191–198. 7 indexed citations
15.
Cross, Jane L., et al.. (2012). Peptides targeting the mitogen-activated protein kinase pathway (JNK/Jun) fail to reduce infarct volume after permanent MCAO in Sprague Dawley rats. UWA Profiles and Research Repository (UWA). 5(1). 22–30. 1 indexed citations
16.
Cross, Jane L., Dominic Simring, Toby Richards, P. Harris, & Krassi Ivancev. (2011). Classification of the aortic visceral segment by zones. International Journal of Surgery. 9(7). 568–569. 1 indexed citations
17.
Cross, Jane L., et al.. (2010). Modes of Neuronal Calcium Entry and Homeostasis following Cerebral Ischemia. Stroke Research and Treatment. 2010. 1–9. 59 indexed citations
18.
Meloni, Bruno P., Jane L. Cross, Anthony J. Bakker, et al.. (2009). AP‐1 inhibitory peptides are neuroprotective following acute glutamate excitotoxicity in primary cortical neuronal cultures. Journal of Neurochemistry. 112(1). 258–270. 34 indexed citations
19.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Xiaofei Ji Breakdown of academic impact, for papers by Mohammed Al‐Hawwas Breakdown of academic impact, for papers by Jie Peng Breakdown of academic impact, for papers by Zhanwen He Breakdown of academic impact, for papers by Kiersten L. Berggren Breakdown of academic impact, for papers by Moon‐Sook Woo Breakdown of academic impact, for papers by Takuro Kobori Breakdown of academic impact, for papers by Breset A. Walker Breakdown of academic impact, for papers by Shengtao Yao
Rankless by CCL
2026